ArticleMolecular and clinical oncology2021

Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line.

Kenji Nakano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.